Athena Philis-Tsimikas is an Endocrinology/Metabolic physician. ClinicalTrials.gov lists 14 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
14 registered studies on ClinicalTrials.gov matched to this name. Itemized trial rows, roles and sponsors are part of the full profile. Why? →
Industry payments
17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novo Nordisk ASProgram year20257 payments$26,998openpaymentsdata.cms.gov ↗
- Eli Lilly and CompanyProgram year202517 payments$10,612openpaymentsdata.cms.gov ↗
- Regeneron Pharmaceuticals, Inc.Program year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
95.1%GLP-1 receptor agonist42%Ozempic71%Mounjaro18%Trulicity11%Part D<11 patientsSGLT2 inhibitor21.2%Jardiance75%Farxiga25%Part D<11 patients+ 3 more classes in this area
Nervous system
4.9%Tricyclic Antidepressant4.9%Amitriptyline Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
8 NIH research awards on record, funded 2006–2026 per NIH RePORTER. The latest:
- CTSA K12 Program at The Scripps Research Institute
Scripps Research Institute, the
FY2026$971,929K12TR004410 - Enhancing Dulce Digital with CGM-driven Personalization, Peer support, Gamification, and Engagement (EDGE) to Improve T2D Self-Management
Scripps Health
FY2026$574,932R01DK149282 - CTSA K12 Program at The Scripps Research Institute
Scripps Research Institute, the
FY2025$971,929K12TR004410
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Yousef Saleh Khader
Jordan University of Science and Technology
Jens Juul Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Christos Mantzoros, MD
Harvard Medical School
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”